logo-large
  • Browse Categories

Publications by authors named "N Sejic"

Claim this Profile
C
Characterizing and Targeting of BCL-2 Family Members in Nasopharyngeal Carcinoma.
A A Thai, R J Young, M Bressel, G L Kelly, N Sejic

Head Neck· March 2025


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human clinical trial of allogeneic, platelet-derived extracellular vesicles as a potential therapeutic for delayed wound healing.
Jancy Johnson, Sam Q K Law, Mozhgan Shojaee, Alex S Hall, Sadman Bhuiyan, Nenad Sejic

J Extracell Vesicles· July 2023


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCL-XL inhibition by BH3-mimetic drugs induces apoptosis in models of Epstein-Barr virus-associated T/NK-cell lymphoma.
Nenad Sejic, Lindsay C George, Rosemary J Tierney, Catherine Chang, Olga Kondrashova

Blood Adv· October 2020


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins.
Leah Fitzsimmons, Rachel Cartlidge, Catherine Chang, Nenad Sejic, Laura C A Galbraith

Cell Death Differ· May 2020


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: